https://endpts.com

Endpoints News – Biotech, drug, pharma and health news for business and professional readersBiotech, drug, pharma and health news for business and professional readersEndpoints News – Biotech, drug, pharma and health news for business and professional readers Channels All News In Focus Special AI Bioregnum Biotech Voices Cell/Gene Tx China Coronavirus Deals Diagnostics Discovery FDA+ Financing Health Tech Law Letters to the Editor Manufacturing Marketing Nikkei Biotechnology Opinion Outsourcing Peer Review People Pharma R&D Startups Weekly Webinars Biopharma Jobs More Work at Endpoints Letter to Editors Editorial Standards IPO Tracker Webinars Events Sponsored Posts Advertise Privacy Policy Endpoints Merch About Us Help SIGN UP LOG IN top stories Pfiz­er tees up Phase 3 test in weight man­age­ment — but in an un­ex­pect­ed area Yesterday R&D GSK, iTeos re­ju­ve­nate strug­gling TIG­IT space with pos­i­tive Phase 2 Jem­per­li com­bo da­ta in lung can­cer Yesterday R&D In­cyte gears up to face FDA once again with more Zynyz da­ta in rare anal can­cer 22 hours ago R&D Latest Most read SEC probe of Il­lu­mi­na’s Grail deal tar­gets sales fore­casts, sources say Yesterday DealsLaw Bris­tol My­ers touts LAG-3 strat­e­gy in lung can­cer as it preps for show­down with Mer­ck’s Keytru­da Yesterday R&D House pass­es Biose­cure Act; Mod­er­na out­lines more cost cuts; What's hap­pen­ing at #ES­MO24; and more Yesterday Weekly Nu­va­tion Bio to head to FDA with pooled ROS1-pos­i­tive lung can­cer da­ta Yesterday R&D see latest stream People Ar­bor Biotech­nolo­gies cuts ear­ly-stage dis­cov­ery work, lays off staff Yesterday Au­rinia re­struc­tures board, bring­ing in Kevin Tang and keep­ing CEO Yesterday Charles Riv­er to lay off 3% of staffers as it stream­lines spend­ing 2 days ago Financing Bicara, Zenas and MBX rekin­dle IPO mar­ket with rare Fri­day triple­head­er 2 days ago Sofinno­va’s Jim Healy on ‘more ra­tio­nal mar­ket’ as four biotech star­tups near their IPOs 2 days ago A new start­up wants to fight can­cer with 'off-the-shelf' gene ther­a­py, se­cur­ing $26M seed round 3 days ago Startups F2G inks $100M Se­ries H for an­oth­er shot at treat­ing fun­gal in­fec­tions 3 days ago Ra­di­ant Bio snags $35M for an­ti­body plat­form, with GSK and Re­gen­eron part­ner­ships 4 days ago Ex­clu­sive: A male con­tra­cep­tive may pre­vent 99% of preg­nan­cies. Now it’s up to a small biotech to fin­ish test­ing it 4 days ago Deals De­bio­pharm, ITM ink €300M li­cens­ing deal for can­cer treat­ment 2 days ago Sanofi buys in­to ra­dio­phar­ma­ceu­ti­cal field with $110M up­front, go­ing af­ter space held by No­var­tis 3 days ago Gilead part­ners with AI start­up Gen­e­sis Ther­a­peu­tics to make small mol­e­cule drugs 4 days ago In FocusSee all Re­cur­sion nears ‘mo­ment of truth’ with first key da­ta, kick­ing off 18-month flur­ry of read­outs 3 weeks ago R&DAI Once one of im­muno-on­col­o­gy's next great hopes, CD47 faces fi­nal shots on goal 3 weeks ago R&D The obe­si­ty drug race is be­ing fought on the man­u­fac­tur­ing floor as GLP-1 ri­vals make plans to catch lead­ers Last month PharmaManufacturing A teenag­er faced con­stant seizures. Could a drug de­vel­oped just for him stop them? 2 months ago R&DDiscovery Endpoints Standouts How the world's biggest phar­ma and biotech com­pa­nies paid their typ­i­cal work­er in 2023 2 months ago PeoplePharma In biotech's un­even re­cov­ery, 50 star­tups raised megarounds in first half of 2024 2 months ago FinancingStartups Bio­phar­ma lead­ers chart­ing a path for the in­dus­try's LGBTQ+ com­mu­ni­ty 2 months ago PeopleSpecial Pe­ter Marks sin­gle-hand­ed­ly ap­proved Sarep­ta’s gene ther­a­py — what does that mean for every­one else? 2 months ago PharmaCell/Gene Tx Peer review See all Sep 13 Doug Williams re­turns with a ‘FIT’ bet on CAR-Ts; Bio­gen ap­points Mene Pan­ga­los to board Sep 6 Roche's Spark los­es CEO to RNA up­start; Ex-El­e­va­tion On­col­o­gy chief takes over at Af­fimed Aug 30 J&J's hu­man re­sources leader to re­tire; Am­gen be­comes the newest phar­ma with a top AI ex­ec Aug 23 Gen­mab makes two C-suite ad­di­tions as COO leaves; James Sabry leads a re­vamped sup­port­ing cast at Bio­Marin Aug 16 Es­pe­ri­on's CMO hits the ex­it; Pfiz­er ap­points Nvidia alum as AI chief Pharma channel feed Yesterday Ad­comm says In­ter­cep­t's rare liv­er dis­ease drug should not get full ap­proval An FDA ad­vi­so­ry com­mit­tee rec­om­mend­ed against full ap­proval for Al­fasig­ma and In­ter­cept Phar­ma­ceu­ti­cals’ rare liv­er dis­ease drug Ocali­va by a 13-1 vote, con­clud­ing that con­fir­ma­to­ry ... READ MORE FDA ap­proves sub­cu­ta­neous Ocre­vus, broad­en­ing ac­cess to Roche and Genen­tech block­buster Yesterday FDA+ WHO pre-qual­i­fies Bavar­i­an Nordic’s vac­cine as first mpox shot Yesterday Manufacturing latest in Pharma On­line stim­u­lant pre­scrip­tions soared dur­ing Covid pan­dem­ic, study finds Yesterday Health Tech Cor­rect­ed: Roche’s Tecen­triq scores first US ap­proval for sub­cu­ta­neous PD-L1 2 days ago FDA+ Avadel's nar­colep­sy drug Lum­ryz miss­es PDU­FA date, still un­der re­view at FDA 2 days ago FDA+ FDA should em­brace new ways of eval­u­at­ing rare dis­ease drugs, re­port ar­gues 2 days ago FDA+ Gilead says twice-year­ly HIV pre­ven­tion shot suc­ceeds in sec­ond piv­otal tri­al 3 days ago R&D see latest stories Marketing channel feed 3 days ago FDA crit­i­cizes Ab­b­Vie's 'mis­lead­ing' ad with Ser­e­na Williams The FDA's Of­fice of Pre­scrip­tion Drug Pro­mo­tion sent a let­ter to Ab­b­Vie late last month, call­ing out the com­pa­ny for what it said was a mis­lead­ing mi­graine drug tele­vi­sion ad­ver­tise­ment, ... READ MORE Up­dat­ed: Madri­gal fi­nal­ly re­veals first wave of sales for MASH drug Rezd­if­fra Last month Pharma RSV mar­ket pres­sure leads to slow­er launch for Mod­er­na's vac­cine Last month Pharma latest in Marketing Verona inks fi­nanc­ing deal worth up to $650M ahead of COPD de­ci­sion 4 months ago Financing From the ed­i­tor: Our fi­nal edi­tion of End­points Mar­ket­ingRx 4 months ago Editor's note Mar­ket­ingRx roundup: Mod­er­na de­buts so­cial me­dia sci­ence se­ries; Boehringer ex­pands NY men­tal health ex­hib­it 4 months ago Pharma Re­al Chem­istry de­buts a one-stop dash­board for all things GLP-1 4 months ago Pharma Phar­ma rep­u­ta­tion slips among pa­tient ad­vo­ca­cy groups, ac­cord­ing to an­nu­al sur­vey 4 months ago Pharma see latest stories FDA+ channel feed 2 days ago FDA re­vis­its new struc­ture for drug re­view doc­u­ments, aim­ing to bet­ter ex­plain its de­ci­sions Back in 2019, as part of a pro­gram fo­cused on im­prov­ing doc­u­men­ta­tion and com­mu­ni­ca­tions for drug ap­provals, the FDA made a change to how it ex­plains its de­ci­sions. READ MORE J&J ex­pands Trem­fya in­to IBD with new FDA ap­proval 3 days ago Pharma FDA is poised to pull Ocali­va as ad­comm doc­u­ments ques­tion post-ap­proval study re­sults 3 days ago Pharma latest in FDA+ FDA drafts new strat­e­gy to boost the use of ad­vanced man­u­fac­tur­ing tech 3 days ago Manufacturing Sanofi, Re­gen­eron to re­file Dupix­ent for skin con­di­tion af­ter new study win 4 days ago R&D Con­gress spars over whether the Biose­cure Act is an over­due crack­down or a rushed witch hunt 4 days ago ChinaManufacturing FDA sends warn­ing let­ter to In­di­an drug­mak­er af­ter find­ing glass in in­jec­tions  4 days ago Manufacturing FDA ad­vi­sors ques­tion whether Iterum's ap­pli­ca­tion for a UTI an­tibac­te­r­i­al is re­stric­tive enough 5 days ago Pharma see latest stories Manufacturing channel feed 2 days ago Aus­tralian RNA man­u­fac­tur­er launch­es; Forge Bi­o­log­ics’ CEO steps down Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial news on new builds, col­lab­o­ra­tions, re­calls and more. READ MORE Lil­ly bud­gets $1.8B to boost Kisun­la, GLP-1 man­u­fac­tur­ing in Ire­land 2 days ago Sanofi opens ‘world first’ mod­u­lar vac­cines and bi­o­log­ics fac­to­ry in France  3 days ago latest in Manufacturing Pan­Tera rais­es €93M to ‘rad­i­cal­ly im­prove sup­ply’ of ac­tini­um for ra­dio­ther­a­peu­tics  4 days ago Financing GSK to shut down UK an­tibi­ot­ic fa­cil­i­ty fol­low­ing end of San­doz con­tract 4 days ago Pharma House pass­es Biose­cure Act, send­ing Chi­nese biotech ban to Sen­ate 5 days ago ChinaLaw Astel­las to close fa­cil­i­ty in Cal­i­for­nia; Take­da can make more of its AD­HD drug Last week With $200M in­vest­ment, No­var­tis builds out ra­di­oli­gand man­u­fac­tur­ing at two sites Last week Pharma see latest stories Bioscience & Technology Business CenterThe University of KansasLawrence, Kansas Latest All News Special In Focus Channels AI Bioregnum Biotech Voices Cell/Gene Tx China Coronavirus Deals Diagnostics Discovery FDA+ Financing Health Tech Law Letters to the Editor Manufacturing Marketing Nikkei Biotechnology Opinion Outsourcing Peer Review People Pharma R&D Startups Weekly More Work at Endpoints Letter to Editors Editorial Standards IPO Tracker Events Webinars Sponsored Posts Advertise Endpoints Merch About Us Help Work in biotech Endpoints Careers © Endpoints News 2024 Help Advertise Privacy Policy Business Model Log in to your account email password Change my password Get a magic email link LOG IN request magic link If you're already an Endpoints subscriber, enter your email below for a magic link that lets you log in quickly without using a password. Please note the magic link is one-time use only and expires after 24 hours. email BACK REQUEST reset password We'll e-mail you a link to set a new password. Please note this link is one-time use only and is valid for only 24 hours. email BACK RESET Sign up for free to read a limited number of articles each month. About You Newsletter Interests Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS NEWS Daily at 11:30 AM ET EARLY EDITION Daily at 7:15 AM ET ENDPOINTS PHARMA Daily at 3:30 PM ET BREAKING NEWS ALERTS 2-3 times a week ENDPOINTS FDA+ Wed at 2 PM ET ENDPOINTS MANUFACTURING Thu at 2 PM ET ENDPOINTS WEEKLY Sat at 6 AM ET POST-HOC 1-2 times a week Healthcare ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET BREAKING NEWS ALERTS 2-3 times a week INSTANT SIGN UP Want unlimited access? Sign up for a premium subscription plan.enen1729138863https://endpts.com

Edit your site?

What are you doing?